Business Wire

OHE

Share
The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report

A new report published today reveals that adult vaccination programmes can return up to 19 times their initial investment when the full spectrum of economic and societal benefits is valued. The 19x return is equivalent to up to USD 4,637 in net monetary benefits to society per individual full vaccination course.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240417519822/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Learn more about the economic benefits of investing in adult immunisation programmes in a new study by the Office of Health Economics (OHE). Graphic: OHE

The study, a first-of-its-kind analysis of adult immunisation programmes by the Office of Health Economics (OHE) and commissioned by IFPMA (1), looked at four adult vaccines across ten countries where they are available to determine the wider economic and social impact.

Focusing on vaccines that protect against influenza (flu), pneumococcal disease, respiratory syncytial virus (RSV), and herpes zoster (shingles), the research looks at the delivery of vaccine programmes in countries that represent a range of healthcare systems, demographics, and vaccine schedules - Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, and the United States.

The report concludes that the vaccination programmes deliver substantial returns on government investment through cost savings within healthcare systems and wider socio-economic benefits. Preventing illness reduces doctor and hospital visits, meaning valuable resources can be allocated elsewhere, and ensuring a healthy and active workforce throughout life can boost economic productivity.

The data also demonstrates that adult immunisation can deliver socio-economic returns proportional to childhood immunisation programmes (2). Despite this, access to adult vaccination is inconsistent around the world, with limited inclusion in routine immunisation schedules.

Professor Lotte Steuten, Deputy CEO of OHE, and co-author of the report, said:

“Increasing pressures on ailing healthcare systems, such as ageing populations, are driving an urgent need to shift to a prevention-first mindset. Our report sets out a compelling case for adult immunisation programmes playing a key role in the shift to prevention.

Our findings show that costs are offset multiple times over by benefits to society when governments invest in adult immunisation programmes. These returns are realised through benefits to individuals, families, and communities, providing a clear call to action to countries not already implementing or expanding robust vaccination schedules.”

The researchers used an established vaccine value framework to gather evidence but discovered a lack of data across many elements. This finding, coupled with a lack of agreed methods for capturing some elements, means the positive returns shown are likely to be underestimates of the full value that adult vaccines bring to society.

The report has been released ahead of the WHO’s World Immunisation Week, and addressing such evidence gaps will be critical in meeting the ambition of the Immunization Agenda 2030. This includes a strategic priority to ensure that ‘all people benefit from recommended immunizations throughout the life-course’ and explicitly outlines the need for data guided implementation.

Laetitia Bigger, IFPMA Vaccines Policy Director, added:

“This important study widens the lens to demonstrate that adult vaccination programmes are delivering real benefits for health systems and societies across the globe.

Vaccines are one of the most effective public health measures and can also be a powerful driver of more productive economies and resilient societies.

“It is critical that these benefits are better understood if we are to ensure that people who can benefit from adult immunisation programmes are able to access them.”

Maarten Postma, Professor in Pharmacoeconomics at the University of Groningen (Netherlands) and reviewer of the report’s methodology, commented:

“Assessing the value of adult immunisation provides policymakers with a clearer picture of the associated benefits and costs. This comprehensive report looked at four adult vaccines internationally and employed a rigorous methodological framework to assess their value."

(1) The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is the innovative pharmaceutical industry’s representative in official relations with the United Nations.

(2) Using the value-of-a-statistical-life approach, return on investment for 10 childhood vaccination programmes was 51.0 from 2011 to 2020 and 52.2 from 2021 to 2030 (Source: https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00103).

- ENDS -

Notes to editors

About the report

The full report ‘The Socio-Economic Value of Adult Immunisation Programmes’ is available at: https://www.ohe.org/publications/the-socio-economic-value-of-adult-immunisation-programmes/

About OHE

With over 60 years of expertise, the Office of Health Economics (OHE) is the world’s oldest independent health economics research organisation. Every day we work to improve health care through pioneering and innovative research, analysis, and education.

As a global thought leader and publisher in the economics of health, health care, and life sciences, we partner with Universities, Government, health systems and the pharmaceutical industry to research and respond to global health challenges.

As a government–recognised Independent Research Organisation and not–for–profit, our international reputation for the quality and independence of our research is at the forefront of all we do. OHE provides independent and pioneering resources, research and analyses in health economics, health policy and health statistics. Our work informs decision–making about health care and pharmaceutical issues at a global level.

All of our work is available for free online at www.ohe.org

About IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240417519822/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AEVEX Achieves AS9100 Certification6.2.2025 16:18:00 CET | Press release

AEVEX Aerospace, a global leader in cutting-edge unmanned systems and services, is proud to announce it has been awarded the prestigious AS9100 certification for its Tampa, Florida facility. This internationally recognized standard provides the framework for developing and implementing quality management systems within the aviation, space, and defense industry. Achieved in just 9 months from official project launch, this certification further demonstrates the AEVEX commitment to delivering world-class products to the aerospace and defense markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250206206147/en/ AEVEX Aerospace achieves AS9100 certification, reinforcing its commitment to quality, innovation, and excellence in aerospace and defense. (Graphic: Business Wire) AS9100, an industry-specific enhancement of ISO9001, establishes a set of robust quality management requirements to ensure the reliable delivery of safe, hi

Rimini Street Celebrates the 10th Anniversary of its Corporate Foundation with a $100,000 RMNI LOVE Charitable Grant Giveaway6.2.2025 15:00:00 CET | Press release

Company’s self-funded charitable program invites certified charities in select cities to apply for one of ten $10,000 grants Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, the leading third-party support provider for Oracle, SAP and VMware software, today announced a $100,000 RMNI LOVE Charitable Grant Giveaway, commemorating the 10th anniversary of its self-funded philanthropic program, the Rimini Street Foundation. Registered charities in select cities across the globe, where a concentrated number of Rimini Street employees and clients are represented, are invited to apply for one of ten $10,000 grants, to be awarded throughout 2025 at various in-person gatherings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250206639812/en/ Rimini Street Celebrates the 10th Anniversary of its Corporate Foundation with a $100,000 RMNI LOVE Charitable Grant Giveaw

A Beloved Classic Just Got Sweeter Than Ever; Candy Crush Solitaire™ Launches Worldwide6.2.2025 14:00:00 CET | Press release

King, the interactive entertainment company behind the world-famous Candy Crush® franchise, today launches Candy Crush Solitaire™on mobile devices worldwide. Candy Crush Solitaire brings a fresh take to the classic card game, combining the timeless fun of solitaire with the vibrant and colorful world of Candy Crush. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250206977362/en/ Candy Crush Solitaire gameplay (Graphic: King) Candy Crush Solitaire offers players a fun, mentally stimulating challenge, combining the familiar gameplay of TriPeaks solitaire with challenging levels, innovative gameplay, and tasty rewards, as they are immersed into the sensory and whimsical Candy Crush universe. Beloved characters join players on a sweet journey around the world, collecting Candified postcards and delicious rewards as they progress through the game, solving puzzles and stacking cards. This new mobile game offering will launch with

Saudi Sports for All Federation Unveils Riyadh Marathon Route, Venues, and Sponsors for Inaugural SFA International Sporting Events6.2.2025 13:41:00 CET | Press release

The Saudi Sports for All Federation (SFA) has announced key details for the inaugural 2025 SFA International Sporting Events, which include the SFA Expo and Riyadh Marathon. The SFA Expo will take place from February 5-7, 2025, at Riyadh’s JAX District, while the Riyadh Marathon is set for Saturday, February 8, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250206409638/en/ Saudi Sports for All Federation Unveils Riyadh Marathon Route, Venues, and Sponsors for Inaugural SFA International Sporting Events (Photo: AETOSWire) The SFA Expo will serve as the marathon’s bib collection hub and will feature interactive zones focused on sports, health, and fitness, showcasing cutting-edge equipment, wellness activities, and emerging technologies. The event will also include a B2B lounge for industry networking, and workshops on mindfulness and nutrition. Another highlight will be the Primal Race on Friday, February 7, a function

Align Partners Submits Shareholder Proposals at Coway Co., Ltd. to Protect the Interests of Minority Shareholders6.2.2025 13:00:00 CET | Press release

Proposals follow Coway’s failure to respond to governance concerns surrounding how the Board manages conflicts of interest with its largest shareholder, Netmarble.Align submitted shareholder proposals to strengthen the independent oversight mechanism at Coway by nominating an independent governance and capital markets expert.To ensure minority shareholder representation is upheld, and meet market best practice, Align is also proposing Coway to introduce cumulative voting. Align Partners Capital Management Inc. ("Align Partners"), a shareholder of Coway Co., Ltd. ("Coway" or "Company") since 2023, submitted 4 shareholder proposals on February 6, 2025, for the upcoming Annual General Meeting (“AGM”). These proposals aim to ensure that Coway’s governance works for all, and not just its largest shareholder. More specifically, Align Partners will be seeking support to appoint Namuh Rhee, an independent governance and capital markets expert and Chair of the Korea Corporate Governance Forum,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye